Disorders of glucose metabolism: Post mortem analyses in forensic cases-part II

International Journal of Legal Medicine

Volumn 125, Issue 2, 2011, Pages 171-180

  Musshoff, Frank ^a   Hess, Cornelius ^a   Madea, Burkhard ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

C peptide; Diabetic ketoacidosis; Hyperosmolar coma; Synthetic insulin

Indexed keywords

C PEPTIDE; INSULIN; KETONE BODY; PROINSULIN;

ARTICLE; BLOOD; CADAVER; DIABETIC KETOACIDOSIS; DISORDERS OF CARBOHYDRATE METABOLISM; FORENSIC PATHOLOGY; HUMAN; INTOXICATION;

C-PEPTIDE; DIABETIC KETOACIDOSIS; FORENSIC PATHOLOGY; GLUCOSE METABOLISM DISORDERS; HUMANS; INSULIN; KETONE BODIES; OVERDOSE; POSTMORTEM CHANGES; PROINSULIN;

EID: 79955917526     PISSN: 09379827     EISSN: 14371596     Source Type: Journal    
DOI: 10.1007/s00414-010-0510-0     Document Type: Review

References (148)

1. Patel F (1994) Diabetic death bed: post-mortem determination of hypoglycaemia. Med Sci Law 34:84-87 (Pubitemid 24026878)
2. Hess C, Musshoff F, Madea M (2010) Disorders of glucose metabolism-post mortem analyses in forensic cases-Part I. Int J Leg Med. doi:10.1007/s00414-010- 0509-6
3. Peclet C, Picotte P, Jobin F (1994) The use of vitreous humor levels of glucose, lactic acid and blood levels of acetone to establish antemortem hyperglycemia in diabetics. Forensic Sci Int 65:1-6 (Pubitemid 24112954)
4. Kernbach G, Puschel K, Brinkmann B (1986) Biochemical measurements of glucose metabolism in relation to cause of death and postmortem effects. Z Rechtsmed 96:199-213 (Pubitemid 16071360)
5. Kitabchi AE, Wall BM (1995) Diabetic ketoacidosis. Med Clin North Am 79:9-37
6. Thomas L (2000) Labor und Diagnose. Indikationen und Bewertung von Laborbefunden für die medizinische Diagnostik, 5th edn. TH Books, Frankfurt
7. Puschel K, Beckmann ER, Kernbach G, Brinkmann B (1984) Differential diagnosis and proof of diabetic coma in the cadaver. Beitr Gerichtl Med 42:315-318 (Pubitemid 14070626)
8. Gormsen H, Lund A (1985) The diagnostic value of postmortem blood glucose determinations in cases of diabetes mellitus. Forensic Sci Int 28:103-107 (Pubitemid 16217991)
9. Denmark LN (1993) The investigation of beta-hydroxybutyrate as a marker for sudden death due to hypoglycemia in alcoholics. Forensic Sci Int 62:225-232 (Pubitemid 24006264)
10. Felby S, Nielsen E (1994) Determination of ketone bodies in postmortem blood by head-space gas chromatography. Forensic Sci Int 64:83-88 (Pubitemid 24089891)
11. Thomsen JL, Felby S, Theilade P, Nielsen E (1995) Alcoholic ketoacidosis as a cause of death in forensic cases. Forensic Sci Int 75:163-171 (Pubitemid 26005023)
12. Brinkmann B, Fechner G, Karger B, DuChesne A (1998) Ketoacidosis and lactic acidosis-frequent causes of death in chronic alcoholics? Int J Leg Med 111:115-119 (Pubitemid 28197814)
13. Pounder DJ, Stevenson RJ, Taylor KK (1998) Alcoholic ketoacidosis at autopsy. J Forensic Sci 43:812-816 (Pubitemid 28323624)
14. Stephens JM, Sulway MJ, Watkins PJ (1971) Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes. Diabetes 20:485-489
15. Cahill GF Jr, Herrera MG, Morgan AP, Soeldner JS, Steinke J, Levy PL, Reichard GA Jr, Kipnis DM (1966) Hormone-fuel interrelationships during fasting. J Clin Invest 45:1751-1769
16. Teale JD, Marks V (1987) The measurement of insulin, C-peptide and b-hydroxybutyrate in the differential diagnosis of spontaneous hypoglycaemia. In: Andreani D (ed) Hypoglycemia. New York. Pearse AG, Raven Press, pp 281-282
17. Iten PX, Meier M, Bär W (1996) ß-Hydroxybuttersäure, ein Indikator für eine alkoholische Ketoacidose als Todesursache bei unerwartet verstorbenen Alkoholikern. 75. DGRM-Jahrestagung, 24.-28.09.1996, Universität Zürich
18. Osuna E, Vivero G, Conejero J, Abenza JM, Martinez P, Luna A, Perez-Carceles MD (2005) Postmortem vitreous humor betahydroxybutyrate: its utility for the postmortem interpretation of diabetes mellitus. Forensic Sci Int 153:189-195 (Pubitemid 41219672)
19. Yamazaki M, Ogura Y, Wakasugi C, Mitsukuni Y, Yoshimura M (1997) Sudden death due to diabetic coma in insulin-department diabetes mellitus: an autopsy report. Nihon Hoigaku Zasshi 51:102-110 (Pubitemid 27251509)
20. Moreau NM, Goupry SM, Antignac JP, Monteau FJ, Le Bizec BJ, Champ MM, Martin LJ, Dumon H (2003) Simultaneous measurement of plasma concentrations and 13C-enrichment of short-chain fatty acids, lactic acid and ketone bodies by gas chromatography coupled to mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 784:395-403 (Pubitemid 36044022)
21. Paik MJ, Cho EY, Kim H, Kim KR, Choi S, Ahn YH, Lee G (2008) Simultaneous clinical monitoring of lactic acid, pyruvic acid and ketone bodies in plasma as methoxime/tert-butyldimethylsilyl derivatives by gas chromatography-mass spectrometry in selected ion monitoring mode. Biomed Chromatogr 22:450-453 (Pubitemid 351722143)
22. Megarbane B, Deye N, Bloch V, Sonneville R, Collet C, Launay JM, Baud FJ (2007) Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles. Crit Care 11:R115
23. Shibutani Y, Ogawa C (2000) Suicidal insulin overdose in a type 1 diabetic patient: relation of serum insulin concentrations to the duration of hypoglycemia. J Diabetes its Complicat 14:60-62 (Pubitemid 30484040)
24. Fasching P, Roden M, Stuhlinger HG, Kurzemann S, Zeiner A, Waldhausl W, Laggner AN (1994) Estimated glucose requirement following massive insulin overdose in a patient with type 1 diabetes. Diabet Med 11:323-325 (Pubitemid 24144151)
25. Lindquist O, Rammer L (1975) Insulin in post-mortem blood. Z Rechtsmed 75:275-277
26. Iwase H, Kobayashi M, Nakajima M, Takatori T (2001) The ratio of insulin to C-peptide can be used to make a forensic diagnosis of exogenous insulin overdosage. Forensic Sci Int 115:123-127
27. Powner DJ, Hendrich A, Lagler RG, Ng RH, Madden RL (1990) Hormonal changes in brain dead patients. Crit Care Med 18:702-708 (Pubitemid 20216233)
28. Thicoipe M, Favarel-Garrigues JF, Masson F, Gin H, de Mascarel A, Angibeau RM, Andre M, Pinaquy C, Feuillerat JP (1991) Endocrine pancreas after brain death: preliminary results. Transplant Proc 23:2481-2482
29. Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA (1988) Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes 37:1470-1477
30. Marks V (1992) Recognition and differential diagnosis of spontaneous hypoglycaemia. Clin Endocrinol (Oxf) 37:309-316
31. Chevenne D, Trivin F, Porquet D (1999) Insulin assays and reference values. Diabetes Metab 25:459-476 (Pubitemid 30003159)
32. Mayors FH, Jawetz E, Goldfein A (1980) Review of Medical Pharrnacology, 7th edn. Lange Medical Publications, Los Altos, California, pp 379-384
33. Guyton (1991) Insulin, Glucagon and Diabetes. In: Textbook of medical physiology, 8th edn. WB Saunders, Philadelphia
34. Lebowitz MR, Blumenthal SA (1993) The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration. Arch Intern Med 153:650-655, (edt).Chapter 78 (Pubitemid 23072394)
35. Katzen HM, Tietze F, Stetten D Jr (1963) Further studies on the properties of hepatic glutathione-insulin transhydro-genase. J Biol Chem 238:1006-1011
36. Marks V (2009) Insulin murders. Med Leg J 77:39-47
37. Mitchell RL (1993) The molar ratio of insulin to C peptide. Arch Int Med 153:650-655
38. Batalis NI, Prahlow JA (2004) Accidental insulin overdose. J Forensic Sci 49:1117-1120 (Pubitemid 39166716)
39. Hampton SM, Beyzavi K, Teale D, Marks V (1988) A direct assay for proinsulin in plasma and its applications in hypoglycaemia. Clin Endocrinol (Oxf) 29:9-16
40. Holstein A, Plaschke A, Egberts EH (2003) Clinical characterisation of severe hypoglycaemia - a prospective population-based study. Exp Clin Endocrinol Diabetes 111:364-369 (Pubitemid 37254614)
41. Service FJ (1991) Hypoglycemias. West J Med 154:442-454
42. Duckworth WC, Kitabchi AE (1981) Insulin metabolism and degradation. Endocr Rev 2:210-233
43. Service FJ (1999) Classification of hypoglycemic disorders. Endocrinol Metab Clin North Am 28:501-517 (Pubitemid 29441319)
44. Marks V, Teale JD (1996) Investigation of hypoglycaemia. Clin Endocrinol (Oxf) 44:133-136 (Pubitemid 26042965)
45. Service FJ (1995) Hypoglycemic disorders. N Engl J Med 332:1144-1152
46. Paroni R, Comuzzi B, Arcelloni C, Brocco S, de Kreutzenberg S, Tiengo A, Ciucci A, Beck-Peccoz P, Genovese S (2000) Comparison of capillary electrophoresis with HPLC for diagnosis of factitious hypoglycemia. Clin Chem 46:1773-1780
47. Vezzosi D, Bennet A, Fauvel J, Caron P (2007) Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol 157:75-83 (Pubitemid 47162569)
48. Hirshberg B, Livi A, Bartlett DL, Libutti SK, Alexander HR, Doppman JL, Skarulis MC, Gorden P (2000) Forty-eight-hour fast: the diagnostic test for insulinoma. J Clin Endocrinol Metab 85:3222-3226
49. Vezzosi D, Bennet A, Fauvel J, Boulanger C, Tazi O, Louvet JP, Caron P (2003) Insulin levels measured with an insulin-specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol 149:413-419 (Pubitemid 37461522)
50. Chia CW, Saudek CD (2003) The diagnosis of fasting hypoglycemia due to an islet-cell tumor obscured by a highly specific insulin assay. J Clin Endocrinol Metab 88:1464-1467 (Pubitemid 36623355)
51. Chammas NK, Teale JD, Quin JD (2003) Insulinoma: how reliable is the biochemical evidence? Ann Clin Biochem 40:689-693 (Pubitemid 37421717)
52. Faber OK, Kehlet H, Madsbad S, Binder C (1978) Kinetics of human C-peptide in man. Diabetes 27(Suppl 1):207-209 (Pubitemid 8303574)
53. Villaume C, Dollet JM, Beck B, Vaillant G, Drouin P, Debry G (1982) Hyperinsulinemia associated with normal C-peptide levels in a woman treated with isoniazide. Biomed Pharmacother 36:32-35 (Pubitemid 12046082)
54. Duckworth WC, Bennett RG, Hamel FG (1998) Insulin degradation: progress and potential. Endocr Rev 19:608-624 (Pubitemid 28467714)
55. Duckworth WC, Hamel FG, Peavy DE (1988) Hepatic metabolism of insulin. Am J Med 85:71-76 (Pubitemid 19012375)
56. Duckworth WC (1988) Insulin degradation: mechanisms, products, and significance. Endocr Rev 9:319-345
57. Duckworth WC, Runyan KR, Wright RK, Halban PA, Solomon SS (1981) Insulin degradation by hepatocytes in primary culture. Endocrinology 108:1142-1147 (Pubitemid 11079127)
58. Kuerzel GU, Shukla U, Scholtz HE, Pretorius SG, Wessels DH, Venter C, Potgieter MA, Lang AM, Koose T, Bernhardt E (2003) Biotransformation of insulin glargine after subcutaneous injection in healthy subjects. Curr Med Res Opin 19:34-40 (Pubitemid 36378318)
59. Thevis M, Thomas A, Schanzer W (2008) Mass spectrometric determination of insulins and their degradation products in sports drug testing. Mass Spectrom Rev 27:35-50 (Pubitemid 350279865)
60. Seabright PJ, Smith GD (1996) The characterization of endosomal insulin degradation intermediates and their sequence of production. Biochem J 320:947-956 (Pubitemid 27013814)
61. Authier F, Danielsen GM, Kouach M, Briand G, Chauvet G (2001) Identification of insulin domains important for binding to and degradation by endosomal acidic insulinase. Endocrinology 142:276-289 (Pubitemid 32183689)
62. Fawcett J, Rabkin R (1995) Sequential processing of insulin by cultured kidney cells. Endocrinology 136:39-45
63. Thomas A, Thevis M, Delahaut P, Bosseloir A, Schanzer W (2007) Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. Anal Chem 79:2518-2524 (Pubitemid 46449034)
64. Kruszynska YT, Home PD, Hanning I, Alberti KG (1987) Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia 30:16-21 (Pubitemid 17017808)
65. Sturner WQ, Putnam RS (1972) Suicidal insulin poisoning with nine day survival: recovery in bile at autopsy by radioimmunoassay. J Forensic Sci 17:514-521
66. Dickson SJ, Cairns ER, Blazey ND (1977) The isolation and quantitation of insulin in post-mortem specimens - a case report. Forensic Sci 9:37-42 (Pubitemid 8048327)
67. Coe JI (1993) Postmortem chemistry update. Emphasis on forensic application. Am J Forensic Med Pathol 14:91-117 (Pubitemid 23180357)
68. Winston DC (2000) Suicide via insulin overdose in nondiabetics: the New Mexico experience. Am J Forensic Med Pathol 21:237-240 (Pubitemid 30667071)
69. Campbell IW, Ratcliffe JG (1982) Suicidal insulin overdose managed by excision of insulin injection site. Br Med J (ClinResEd) 285:408-409 (Pubitemid 12093031)
70. Hood I, Mirchandani H, Monforte J, Stacer W (1986) Immunohistochemical demonstration of homicidal insulin injection site. Arch Pathol Lab Med 110:973-974 (Pubitemid 17178427)
71. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH (1975) Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55:1278-1283 (Pubitemid 8036490)
72. Ostrega D, Polonsky K, Nagi D, Yudkin J, Cox LJ, Clark PM, Hales CN (1995) Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography. Diabetes 44:437-440
73. Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS (1993) Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 76:44-48 (Pubitemid 23027550)
74. Alsever RN, Roberts JP, Gerber JG, Mako ME, Rubenstein AH (1975) Insulinoma with low circulating insulin levels: the diagnostic value of proinsulin measurements. Ann Intern Med 82:347-350
75. Cohen RM, Given BD, Licinio-Paixao J, Provow SA, Rue PA, Frank BH, Root MA, Polonsky KS, Tager HS, Rubenstein AH (1986) Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. Metabolism 35:1137-1146 (Pubitemid 17214178)
76. Gruppuso PA, Gorden P, Kahn CR, Cornblath M, Zeller WP, Schwartz R (1984) Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. N Engl J Med 311:629-634 (Pubitemid 14027326)
77. Yano H, Kitano N, Morimoto M, Polonsky KS, Imura H, Seino Y (1992) A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto). J Clin Invest 89:1902-1907
78. Mako ME, Starr JI, Rubenstein AH (1977) Circulating proinsulin in patients with maturity onset diabetes. Am J Med 63:865-869 (Pubitemid 8251825)
79. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr (1987) Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698-702 (Pubitemid 17159895)
80. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales C (1989) Insulin deficiency in non-insulindependent diabetes. Lancet 1:293-295
81. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY (1995) Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44:173-179
82. Snorgaard O, Kjems LL, Roder ME, Hartling SG, Dinesen B, Binder C (1996) Proinsulin immunoreactivity in recent-onset IDDM: the significance of insulin antibodies and insulin autoantibodies. Diab Care 19:146-150 (Pubitemid 26039136)
83. Clark PM (1999) Assays for insulin, proinsulin(s) and C-peptide. Ann Clin Biochem 36:541-564 (Pubitemid 29410707)
84. Steiner DF, Oyer PE (1967) The biosynthesis of insulin and a probable precursorof insulöin by a human islet cell adenoma. Proc Natl Acad Sci USA 57:473-480
85. Roth J, Gorden P, Pastan I (1968) "Big insulin": a new component of plasma insulin detected by immunoassay. Proc Natl Acad Sci USA 61:138-145
86. Given BD, Cohen RM, Shoelson SE, Frank BH, Rubenstein AH, Tager HS (1985) Biochemical and clinical implications of proinsulin conversion intermediates. J Clin Invest 76:1398-1405 (Pubitemid 16193686)
87. Heald AH, Bhattacharya B, Cooper H, Ullah A, McCulloch A, Smellie S, Wark G (2006) Most commercial insulin assays fail to detect recombinant insulin analogues. Ann Clin Biochem 43:306-308 (Pubitemid 44049695)
88. Owen WE, Roberts WL (2004) Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays. Clin Chem 50:257-259 (Pubitemid 38125742)
89. Moriyama M, Hayashi N, Ohyabu C, Mukai M, Kawano S, Kumagai S (2006) Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay. Clin Chem 52:1423-1426 (Pubitemid 43956037)
90. Butter NL, Hattersley AT, Clark PM (2001) Development of a bloodspot assay for insulin. Clin Chim Acta 310:141-150 (Pubitemid 32728343)
91. Sapin R, Le Galudec V, Gasser F, Pinget M, Grucker D (2001) Elecsys insulin assay: free insulin determination and the absence of cross-reactivity with insulin lispro. Clin Chem 47:602-605 (Pubitemid 32222484)
92. Lindstrom T, Hedman CA, Arnqvist HJ (2002) Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs. Diab Care 25:1049-1054 (Pubitemid 41110492)
93. Bowsher RR, Lynch RA, Brown-Augsburger P, Santa PF, Legan WE, Woodworth JR, Chance RE (1999) Sensitive RIA for the specific determination of insulin lispro. Clin Chem 45:104-110 (Pubitemid 29036392)
94. Andersen L, Jorgensen PN, Jensen LB, Walsh D (2000) A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies. Clin Biochem 33:627-633 (Pubitemid 32146198)
95. Kippen AD, Cerini F, Vadas L, Stocklin R, Vu L, Offord RE, Rose K (1997) Development of an isotope dilution assay for precise determination of insulin, C-peptide, and proinsulin levels in non-diabetic and type II diabetic individuals with comparison to immunoassay. J Biol Chem 272:12513-12522 (Pubitemid 27203343)
96. Darby SM, Miller ML, Allen RO, LeBeau M (2001) A mass spectrometric method for quantitation of intact insulin in blood samples. J Anal Toxicol 25:8-14 (Pubitemid 32121093)
97. Van Uytfanghe K, Rodriguez-Cabaleiro D, Stockl D, Thienpont LM (2007) New liquid chromatography/electrospray ionisation tandem mass spectrometry measurement procedure for quantitative analysis of human insulin in serum. Rapid CommunMass Spectrom 21:819-821 (Pubitemid 46340329)
98. Thevis M, Thomas A, Delahaut P, Bosseloir A, Schanzer W (2006) Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry. Anal Chem 78:1897-1903
99. Bristow AF, Das RE (1988) WHO international reference reagents for human proinsulin and human insulin C-peptide. J Biol Stand 16:179-186
100. Rogatsky E, Tomuta V, Cruikshank G, Vele L, Jayatillake H, Stein D (2006) Direct sensitive quantitative lC/MS analysis of C-peptide from human urine by two dimensional reverse phase/ reverse phase high-performance liquid chromatography. J Sep Sci 29:529-537
101. Fierens C, Stockl D, Baetens D, De Leenheer AP, Thienpont LM (2003) Standardization of C-peptide measurements in urine by method comparison with isotope-dilution mass spectrometry. Clin Chem 49:992-994 (Pubitemid 36623492)
102. Fierens C, Thienpont LM, Stockl D, Willekens E, De Leenheer AP (2000) Quantitative analysis of urinary C-peptide by liquid chromatography-tandem mass spectrometry with a stable isotopically labelled internal standard. J Chromatogr A 896:275-278
103. Given BD, Ostrega DM, Polonsky KS, Baldwin D Jr, Kelley RI, Rubenstein AH (1991) Hypoglycemia due to surreptitious injection of insulin. Identification of insulin species by highperformance liquid chromatography. Diab Care 14:544-547
104. Rodriguez-Cabaleiro D, Stockl D, Thienpont LM (2005) Improvement of sample pretreatment prior to analysis of C-peptide in serum by isotope-dilution liquid chromatography/ tandem mass spectrometry. Rapid Commun Mass Spectrom 19:3600-3602 (Pubitemid 41691936)
105. Muhm M, Berlanovich A (1991) Zur Möglichkeit der postmortalen Dianose einer exogenen Insulinintoxikation. Zentrabl Rechtsmed 36:175-176
106. Stofer AR (1970) Suicide with insulin and demonstration of insulin post mortem. Arch Toxikol 26:1-7
107. O'Rahilly S, Burnett MA, Smith RF, Darley JH, Turner RC (1987) Haemolysis affects insulin but not C-peptide immunoassay. Diabetologia 30:394-396 (Pubitemid 17094610)
108. Authier F, Posner BI, Bergeron JJ (1996) Insulin-degrading enzyme. Clin Invest Med 19:149-160 (Pubitemid 26225900)
109. Brodal BP (1971) Evidence of an enzymatic degradation of insulin in blood in vitro. Eur J Biochem 18:201-206
110. Duckworth WC, Hamel FG, Bennett R, Ryan MP, Roth RA (1990) Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin. J Biol Chem 265:2984-2987
111. Haibach H, Dix JD, Shah JH (1987) Homicide by insulin administration. J Forensic Sci 32:208-216
112. Fletcher SM, Richards L, Moffat AC (1979) The detection of fatal insulin poisoning by tissue analysis. Vet Hum Toxicol 21 (Suppl):197-199 (Pubitemid 10240572)
113. Walters E, Henley R, Barnes I (1986) Stability of insulin in normal whole blood. Clin Chem 32:224
114. Brodal BP (1971) The influence of haemolysis on the radioimmunoassay of insulin. Scand J Clin Lab Invest 28:287-290
115. Myrick JE, Gunter EW, Maggio VL, Miller DT, Hannon WH (1989) An improved radioimmunoassay of C-peptide and its application in a multiyear study. Clin Chem 35:37-42 (Pubitemid 19046780)
116. Smith S, Tolliday U, Shakespear R, Hartland A, Clark PM (1996) Stability of samples for insulin, proinsulin and C-peptide. J Endocrinol 151 (Suppl.):20
117. Bray M (1984) The effect of chilling, freezing, and rewarming on the postmortem chemistry of vitreous humor. J Forensic Sci 29:404-411 (Pubitemid 14134022)
118. Livesey JH, Hodgkinson SC, Roud HR, Donald RA (1980) Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin Biochem 13:151-155 (Pubitemid 11221681)
119. Kubasik NP, Ricotta M, Hunter T, Sine HE (1982) Effect of duration and temperature of storage on serum analyte stability: examination of 14 selected radioimmunoassay procedures. Clin Chem 28:164-165 (Pubitemid 12209780)
120. Shi K, Yokono K, Baba S, Roth RA (1996) Purification and characterization of Insulin-Degrading Enzyme from human erythrocytes. Diabetes 35:675-683
121. Sapin R, Ongagna JC, Gasser F, Grucker D (1998) Insulin measurements in haemolysed serum: influence of insulinase inhibitors. Clin Chim Acta 274:111-117 (Pubitemid 28243268)
122. Wroblewski VJ, Masnyk M, Khambatta SS, Becke GW (1992) Mechanisms involved in degradation of human insulin by cytosolic fractions of human, monkey, and rat liver. Diabetes 41:539-547
123. Fletcher SM (1983) Insulin. A forensic primer. J Forensic Sci Soc 23:5-17 (Pubitemid 13116026)
124. Vogeser M, Parhofer KG (2005) Limited preanalytical requirements for insulin measurement. Clin Biochem 38:572-575 (Pubitemid 40693472)
125. Sacks DB (1999) Carbohydrates. In: Burtis C, Ashwood E (eds) Tietz textbook of clinical chemistry, 3rd edn. WB Saunders, Philadelphia, pp 750-808
126. Associated Regional and University Pathologists (2009). Available at: http://www.arup-lab.com. Accessed 13 April 2010
127. Fierens C, Thienpont LM, Stockl D, De Leenheer AP (2000) Matrix effect in the quantitative analysis of urinary C-peptide by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 14:936-937 (Pubitemid 30367586)
128. Patel F (1992) Fatal self-induced hyperinsulinaemia: a delayed post-mortem analytical detection. Med Sci Law 32:151-159
129. Burge MR, Schade DS (1997) Insulins. Endocrinol Metab Clin North Am 26:575-598 (Pubitemid 27411474)
130. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer HM, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K (1996) Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes 45:242-256
131. Service FJ, Palumbo PJ (1974) Factitial hypoglycemia. Three cases diagnosed on the basis of insulin antibodies. Arch Intern Med 134:336-340
132. Scarlett JA, Mako ME, Rubenstein AH, Blix PM, Goldman J, Horwitz DL, Tager H, Jaspan JB, Stjernholm MR, Olefsky JM (1977) Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. N Engl J Med 297:1029-1032 (Pubitemid 8228325)
133. Archambeaud-Mouveroux F, Huc MC, Nadalon S, Fournier MP, Canivet B (1989) Autoimmune insulin syndrome. Biomed Pharmacother 43:581-586 (Pubitemid 20077684)
134. Takei M (1980) Insulin antibodies produced by methimazole treatment in patients with Graves-disease. J Tokyo Wom Med Coll 50:54-68 (Pubitemid 10103625)
135. Fushimi H, Tsukuda S, Hanafusa T, Matsuyuki Y, Nishikawa M, Ishihara S, Kanao K (1980) A case of insulin autoimmune syndrome associated with small insulinomas and rheumatoid arthritis. Endocrinol Jpn 27:679-687
136. Deberg M, Houssa P, Frank BH, Sodoyez-Goffaux F, Sodoyez JC (1998) Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors. Clin Chem 44:1504-1513 (Pubitemid 28309112)
137. Cabaleiro DR, Stockl D, Kaufman JM, Fiers T, Thienpont LM (2006) Feasibility of standardization of serum C-peptide immunoassays with isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 52:1193-1196 (Pubitemid 43794435)
138. Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH (1977) Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22-29 (Pubitemid 8061860)
139. Boyko EJ, Keane EM, Marshall JA, Hamman RF (1991) Higher insulin and C-peptide concentrations in Hispanic population at high risk for NIDDM. San Luis Valley Diabetes Study Diabetes 40:509-515
140. Kjems LL, Roder ME, Dinesen B, Hartling SG, Jorgensen PN, Binder C (1993) Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 39:2146-2150 (Pubitemid 23306165)
141. Tillil H, Shapiro ET, Miller MA, Karrison T, Frank BH, Galloway JA, Rubenstein AH, Polonsky KS (1988)Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. Am J Physiol 254:E349-E357
142. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M (2002) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48:436-472 (Pubitemid 34174577)
143. Clarke WL, Cox DJ, Gonder-Frederick LA, Kovatchev B (1999) Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes. JAMA 282:750-754 (Pubitemid 29404381)
144. Marks V, Teale JD (1993) Hypoglycaemia in the adult. Baillières Clin Endocrinol Metab 7:705-729 (Pubitemid 23243434)
145. Service FJ (1995) Hypoglycemia. Med Clin North Am 79:1-8
146. Service FJ, O'Brien PC, McMahon MM, Kao PC (1993) C-peptide during the prolonged fast in insulinoma. J Clin Endocrinol Metab 76:655-659 (Pubitemid 23086482)
147. Aun F, Meguid MM, Soeldner JS, Stolf NA (1975) Urinary insulin levels in health and disease-a concise review. Postgrad Med J 51:622-626
148. Horwitz DL, Rubenstein AH, Katz AI (1977) Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine. Diabetes 26:30-35 (Pubitemid 8097912)